
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Role of Topical Immune Response Modifiers in Skin Cancer
Courtney Woodmansee, Jessica Pillow, Robert B. Skinner
Drugs (2006) Vol. 66, Iss. 13, pp. 1657-1664
Closed Access | Times Cited: 43
Courtney Woodmansee, Jessica Pillow, Robert B. Skinner
Drugs (2006) Vol. 66, Iss. 13, pp. 1657-1664
Closed Access | Times Cited: 43
Showing 1-25 of 43 citing articles:
Effective Innate and Adaptive Antimelanoma Immunity through Localized TLR7/8 Activation
Manisha Singh, Hiep Khong, Zhimin Dai, et al.
The Journal of Immunology (2014) Vol. 193, Iss. 9, pp. 4722-4731
Open Access | Times Cited: 148
Manisha Singh, Hiep Khong, Zhimin Dai, et al.
The Journal of Immunology (2014) Vol. 193, Iss. 9, pp. 4722-4731
Open Access | Times Cited: 148
Depigmentation therapies for normal skin in vitiligo universalis
Khalid M. AlGhamdi, Ashok Kumar
Journal of the European Academy of Dermatology and Venereology (2010) Vol. 25, Iss. 7, pp. 749-757
Closed Access | Times Cited: 89
Khalid M. AlGhamdi, Ashok Kumar
Journal of the European Academy of Dermatology and Venereology (2010) Vol. 25, Iss. 7, pp. 749-757
Closed Access | Times Cited: 89
Cutaneous Melanoma In Situ: Translational Evidence from a Large Population-Based Study
Simone Mocellin, Donato Nitti
The Oncologist (2011) Vol. 16, Iss. 6, pp. 896-903
Open Access | Times Cited: 67
Simone Mocellin, Donato Nitti
The Oncologist (2011) Vol. 16, Iss. 6, pp. 896-903
Open Access | Times Cited: 67
Interventions for the treatment of Paget's disease of the vulva
Katharine Edey, E. Allan, John Murdoch, et al.
Cochrane library (2013)
Closed Access | Times Cited: 59
Katharine Edey, E. Allan, John Murdoch, et al.
Cochrane library (2013)
Closed Access | Times Cited: 59
Melanoma In Situ Treated Successfully Using Imiquimod After Nonclearance with Surgery: Review of the Literature
Lixia Z. Ellis, Joel L. Cohen, Whitney A. High, et al.
Dermatologic Surgery (2012) Vol. 38, Iss. 6, pp. 937-946
Closed Access | Times Cited: 59
Lixia Z. Ellis, Joel L. Cohen, Whitney A. High, et al.
Dermatologic Surgery (2012) Vol. 38, Iss. 6, pp. 937-946
Closed Access | Times Cited: 59
Effectiveness of imiquimod limited to dermal melanoma metastases, with simultaneous resistance of subcutaneous metastasis
Kristin C. Turza, Lynn T. Dengel, Rebecca C. Harris, et al.
Journal of Cutaneous Pathology (2009) Vol. 37, Iss. 1, pp. 94-98
Open Access | Times Cited: 63
Kristin C. Turza, Lynn T. Dengel, Rebecca C. Harris, et al.
Journal of Cutaneous Pathology (2009) Vol. 37, Iss. 1, pp. 94-98
Open Access | Times Cited: 63
Drug therapy of advanced cutaneous squamous cell carcinoma: is there any evidence?
Simone Ribero, Luigia Stefania Stucci, Gregory A. Daniels, et al.
Current Opinion in Oncology (2017) Vol. 29, Iss. 2, pp. 129-135
Open Access | Times Cited: 42
Simone Ribero, Luigia Stefania Stucci, Gregory A. Daniels, et al.
Current Opinion in Oncology (2017) Vol. 29, Iss. 2, pp. 129-135
Open Access | Times Cited: 42
Interventions for the treatment of Paget's disease of the vulva
Katharine Edey, E. Allan, John Murdoch, et al.
Cochrane library (2019) Vol. 2019, Iss. 6
Open Access | Times Cited: 40
Katharine Edey, E. Allan, John Murdoch, et al.
Cochrane library (2019) Vol. 2019, Iss. 6
Open Access | Times Cited: 40
Imiquimod as Local Immunotherapy in the Management of Premalignant Cutaneous Conditions and Skin Cancer
Emilio Garcia‐Mouronte, Emilio Berna‐Rico, Belén de Nicolás-Ruanes, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10835-10835
Open Access | Times Cited: 11
Emilio Garcia‐Mouronte, Emilio Berna‐Rico, Belén de Nicolás-Ruanes, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10835-10835
Open Access | Times Cited: 11
Photothermal therapy improves the efficacy of topical immunotherapy against melanoma
Lei Shi, Fuhe Zhang, Yan Jia, et al.
Photodiagnosis and Photodynamic Therapy (2024) Vol. 49, pp. 104290-104290
Open Access | Times Cited: 3
Lei Shi, Fuhe Zhang, Yan Jia, et al.
Photodiagnosis and Photodynamic Therapy (2024) Vol. 49, pp. 104290-104290
Open Access | Times Cited: 3
Recurrence of Lentigo Maligna and Development of Invasive Melanoma after Treatment of Lentigo Maligna with Imiquimod
Courtney Woodmansee, Michael W. McCall
Dermatologic Surgery (2009) Vol. 35, Iss. 8, pp. 1286-1289
Closed Access | Times Cited: 42
Courtney Woodmansee, Michael W. McCall
Dermatologic Surgery (2009) Vol. 35, Iss. 8, pp. 1286-1289
Closed Access | Times Cited: 42
Intratumoral immunotherapy for melanoma
Manisha Singh, Willem W. Overwijk
Cancer Immunology Immunotherapy (2015) Vol. 64, Iss. 7, pp. 911-921
Open Access | Times Cited: 32
Manisha Singh, Willem W. Overwijk
Cancer Immunology Immunotherapy (2015) Vol. 64, Iss. 7, pp. 911-921
Open Access | Times Cited: 32
Using topical imiquimod for the management of positive in situ margins after melanoma resection
Amrita S. Pandit, Erik J. Geiger, Stephan Ariyan, et al.
Cancer Medicine (2015) Vol. 4, Iss. 4, pp. 507-512
Open Access | Times Cited: 31
Amrita S. Pandit, Erik J. Geiger, Stephan Ariyan, et al.
Cancer Medicine (2015) Vol. 4, Iss. 4, pp. 507-512
Open Access | Times Cited: 31
Therapeutics targeting tumor immune escape: Towards the development of new generation anticancer vaccines
Simone Mocellin, Donato Nitti
Medicinal Research Reviews (2007) Vol. 28, Iss. 3, pp. 413-444
Closed Access | Times Cited: 41
Simone Mocellin, Donato Nitti
Medicinal Research Reviews (2007) Vol. 28, Iss. 3, pp. 413-444
Closed Access | Times Cited: 41
Imiquimod: an immune response modifier in the treatment of precancerous skin lesions and skin cancer
Evangelia Papadavid, Alexandros Stratigos, Matthew E. Falagas
Expert Opinion on Pharmacotherapy (2007) Vol. 8, Iss. 11, pp. 1743-1755
Closed Access | Times Cited: 41
Evangelia Papadavid, Alexandros Stratigos, Matthew E. Falagas
Expert Opinion on Pharmacotherapy (2007) Vol. 8, Iss. 11, pp. 1743-1755
Closed Access | Times Cited: 41
Non-surgical treatments of primary, non-melanoma eyelid malignancies: a review
Ann P. Murchison, Joseph D. Walrath, Carl V. Washington
Clinical and Experimental Ophthalmology (2010), pp. no-no
Closed Access | Times Cited: 36
Ann P. Murchison, Joseph D. Walrath, Carl V. Washington
Clinical and Experimental Ophthalmology (2010), pp. no-no
Closed Access | Times Cited: 36
Update on toll-like receptor-directed therapies for human disease
Kevin Tse, Anthony A. Horner
Annals of the Rheumatic Diseases (2007) Vol. 66, Iss. Supplement 3, pp. iii77-iii80
Open Access | Times Cited: 31
Kevin Tse, Anthony A. Horner
Annals of the Rheumatic Diseases (2007) Vol. 66, Iss. Supplement 3, pp. iii77-iii80
Open Access | Times Cited: 31
Imiquimod use in the treatment of lentigo maligna
Jacqueline M. Junkins‐Hopkins
Journal of the American Academy of Dermatology (2009) Vol. 61, Iss. 5, pp. 865-867
Closed Access | Times Cited: 25
Jacqueline M. Junkins‐Hopkins
Journal of the American Academy of Dermatology (2009) Vol. 61, Iss. 5, pp. 865-867
Closed Access | Times Cited: 25
Mohs Surgery for Melanoma in Situ
Soonyou Kwon, Stanley J. Miller
Dermatologic Clinics (2011) Vol. 29, Iss. 2, pp. 175-183
Closed Access | Times Cited: 23
Soonyou Kwon, Stanley J. Miller
Dermatologic Clinics (2011) Vol. 29, Iss. 2, pp. 175-183
Closed Access | Times Cited: 23
Imiquimod‐induced vitiligo after treatment of nodular basal cell carcinoma
Smitha Gowda, Donald K. Tillman, James E. Fitzpatrick, et al.
Journal of Cutaneous Pathology (2009) Vol. 36, Iss. 8, pp. 878-881
Closed Access | Times Cited: 21
Smitha Gowda, Donald K. Tillman, James E. Fitzpatrick, et al.
Journal of Cutaneous Pathology (2009) Vol. 36, Iss. 8, pp. 878-881
Closed Access | Times Cited: 21
Lupus erythematosus-like imiquimod reaction: a diagnostic pitfall*
Keira Barr, Thomas Konia, Maxwell A. Fung
Journal of Cutaneous Pathology (2010), pp. no-no
Closed Access | Times Cited: 20
Keira Barr, Thomas Konia, Maxwell A. Fung
Journal of Cutaneous Pathology (2010), pp. no-no
Closed Access | Times Cited: 20
Macrophages as a Double-Edged Weapon: The Use of Macrophages in Cancer Immunotherapy and Understanding the Cross-Talk Between Macrophages and Cancer
Ahmed Salah, Yanqin Li, Hao Wang, et al.
DNA and Cell Biology (2021) Vol. 40, Iss. 3, pp. 429-440
Closed Access | Times Cited: 11
Ahmed Salah, Yanqin Li, Hao Wang, et al.
DNA and Cell Biology (2021) Vol. 40, Iss. 3, pp. 429-440
Closed Access | Times Cited: 11
Quinoline Analogs as Antiangiogenic Agents and Telomerase Inhibitors
Mahmud Tareq Hassan Khan
Springer eBooks (2007), pp. 213-229
Closed Access | Times Cited: 16
Mahmud Tareq Hassan Khan
Springer eBooks (2007), pp. 213-229
Closed Access | Times Cited: 16
Bone Invasion by Squamous Cell Carcinoma In Situ (Bowen's Disease) of the Finger During Treatment With Imiquimod 5% Cream: Case Report
Hyun Sik Gong, Jae Hwan Cho, Young Hak Roh, et al.
The Journal Of Hand Surgery (2010) Vol. 35, Iss. 6, pp. 999-1002
Closed Access | Times Cited: 11
Hyun Sik Gong, Jae Hwan Cho, Young Hak Roh, et al.
The Journal Of Hand Surgery (2010) Vol. 35, Iss. 6, pp. 999-1002
Closed Access | Times Cited: 11
Topical imiquimod in the treatment of two cutaneous melanocytomas in a dog
Kimberly S. Coyner, Diana Loeffler
Veterinary Dermatology (2011) Vol. 23, Iss. 2, pp. 145-145
Open Access | Times Cited: 10
Kimberly S. Coyner, Diana Loeffler
Veterinary Dermatology (2011) Vol. 23, Iss. 2, pp. 145-145
Open Access | Times Cited: 10